Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 20,251–20,275 of 27,380 studies, newest first · page 811 of 1096.

March 2011 6

  1. 2011-03-01

    Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment

    ✓ Peer-reviewed Getting a diagnosis Archives of neurology

    Key finding: Dementia due to Alzheimer disease is preceded by about 5 to 6 years of accelerated decline in multiple cognitive functions.

  2. 2011-03-01

    α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

    ✓ Peer-reviewed Getting a diagnosis The Lancet. Neurology

    Key finding: In our training set, people with Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies had lower CSF α-synuclein concentrations than patients with Alzheimer's disease and other neurological disorders.

  3. 2011-03-01

    Alzheimer's disease

    ✓ Peer-reviewed Getting a diagnosis Lancet (London, England)

    Key finding: Thus, Alzheimer's disease represents a major public health concern and has been identified as a research priority. +4 more findings

  4. 2011-03-01

    Vitamin D receptor gene as a candidate gene for Parkinson disease

    ✓ Peer-reviewed Genetics Annals of human genetics

    Key finding: In the discovery dataset, SNPs in the 5' end of VDR were associated with both risk and AAO with more significant evidence of association with AAO (P= 0.0008-0.02). +4 more findings

  5. 2011-03-01

    Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease

    ✓ Peer-reviewed Genetics Neurology

    Key finding: We conclude that FHm individuals without dementia have progressive gray matter volume reductions in select AD-vulnerable brain regions, specifically the precuneus and parahippocampal gyrus. +4 more findings

  6. 2011-03-01

    Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging

    ✓ Peer-reviewed Genetics Neurology

    Key finding: Analysis of cross-sectional data from the AIBL study indicates that plasma apoE levels are altered in AD and correlate with AD pathology level. +4 more findings

February 2011 19

  1. 2011-02-27
  2. 2011-02-27

    Characterizing the RNA targets and position-dependent splicing regulation by TDP-43

    ✓ Peer-reviewed Lewy body dementia Nature neuroscience

    Key finding: Using individual nucleotide-resolution ultraviolet cross-linking and immunoprecipitation (iCLIP), we found that TDP-43 preferentially bound long clusters of UG-rich sequences in vivo. +1 more finding

  3. 2011-02-25

    Exercise-induced myokines and their role in chronic diseases

    ✓ Peer-reviewed Prevention and risk Brain, behavior, and immunity

    Key finding: Accumulating data suggest that contracting skeletal muscles release myokines, which may work in a hormone-like fashion, exerting specific endocrine effects on visceral fat or mediating direct anti-inflammatory effects.

  4. 2011-02-24

    Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment PloS one

    Key finding: In this study, we conducted a genome-wide association study in an independent set of 1034 cases and 1186 controls using the Illumina genotyping platforms. +3 more findings

  5. 2011-02-24

    Why do ethnic elders present later to UK dementia services? A qualitative study

    ✓ Peer-reviewed Disparities International psychogeriatrics

    Key finding: ME carer beliefs were an important barrier to early diagnosis.

  6. 2011-02-23

    Social Cognition in Schizophrenia, Part 1: Performance Across Phase of Illness

    ✓ Peer-reviewed Mild cognitive impairment Schizophrenia Bulletin

    Key finding: Social cognitive impairments are consistently reported in schizophrenia and are associated with functional outcome. +2 more findings

  7. 2011-02-23

    Amyloid β peptide oligomers directly activate NMDA receptors

    ✓ Peer-reviewed Treatments Cell calcium

    Key finding: Consistent with these findings, we observed that the increase in the cytosolic concentration of Ca(2+) induced by Aβ oligomers in cortical neurons is prevented by AP5, a broad spectrum NMDA receptor antagonist, but slightly attenuated by ifenprodil which blocks receptors with the NR2B subunit. +1 more finding

  8. 2011-02-23

    Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort

    ✓ Peer-reviewed Risk factors Sleep medicine

    Key finding: These data suggest that among aged subjects with cognitive impairment and/or parkinsonism, the MSQ has adequate SN and SP for the diagnosis of RBD. +1 more finding

  9. 2011-02-23

    Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies

    ✓ Peer-reviewed Risk factors Obesity reviews : an official journal of the International Association for the Study of Obesity

    Key finding: Low BMI in midlife was associated with 1.96 [95% confidence interval (CI): 1.32, 2.92] times the risk of developing AD. +4 more findings

  10. 2011-02-22

    Advanced care planning in care homes for older people: a qualitative study of the views of care staff and families

    ✓ Peer-reviewed End-of-life care Age and ageing

    Key finding: Design qualitative exploration of views from care home staff and the family of residents in care homes for older people. +1 more finding

  11. 2011-02-22
  12. 2011-02-22

    White matter lesions in Parkinson disease

    ✓ Peer-reviewed Caregiving Nature reviews. Neurology

    Key finding: WMLs are associated with motor and cognitive symptoms in otherwise normal elderly individuals. +2 more findings

  13. 2011-02-19

    The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease

    ✓ Peer-reviewed Digital health tools European journal of nuclear medicine and molecular imaging

    Key finding: PVC was shown to improve the quantitative accuracy of regional analysis performed on amyloid PET images. +1 more finding

  14. 2011-02-17

    Oleuropein and derivatives from olives as Tau aggregation inhibitors

    ✓ Peer-reviewed Drug development Neurochemistry international

    Key finding: These findings might provide further experimental support for the beneficial nutritional properties of olives and olive oil as well as a chemical scaffold for the development of new drugs aiming at neurodegenerative tauopathies.

  15. 2011-02-17

    Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE

    ✓ Peer-reviewed Brain tissue and pathology PLoS genetics

    Key finding: The National Institute of Aging-Late Onset Alzheimer's Disease Family Study and the National Cell Repository for Alzheimer's Disease conducted a joint genome-wide association study (GWAS) of multiplex LOAD families (3,839 affected and unaffected individuals from 992 families plus additional unrelated neurologically evaluated normal subjects) using the 610 IlluminaQuad panel. +3 more findings

  16. 2011-02-16

    Classification of primary progressive aphasia and its variants

    ✓ Peer-reviewed Getting a diagnosis Neurology

    Key finding: This article provides a classification of primary progressive aphasia (PPA) and its 3 main variants to improve the uniformity of case reporting and the reliability of research results.

  17. 2011-02-16

    Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Hippocampal atrophy and amyloid deposition seem to dissociate during the evolution of MCI, the atrophy increasing clearly and [(11)C] PiB retention changing modestly when conversion to AD occurs. +3 more findings

  18. 2011-02-15

    Frequency, risk factors, and prognosis of prolonged delirium in elderly patients after hip fracture surgery

    ✓ Peer-reviewed Clinical safety Clinical orthopaedics and related research

    Key finding: Prolonged delirium was found to be associated with a poor functional outcome and increased mortality. +2 more findings

  19. 2011-02-15

    Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: The intake of the polyunsaturated fatty acid docosahexaenoic acid (DHA) has been associated with decreased amyloid deposition and a reduced risk in Alzheimer disease in several epidemiological trials; however, the exact underlying molecular mechanism remains to be elucidated. +3 more findings

Browse the library by subject, with the full score breakdown →